Evaluation of Galectin-9 blocking mono-clonal antibodies as novel immune-checkpoint inhibitors via the targeting of regulatory T cells in cancer

被引：0
|
作者：
Morel, P. A. [1 ]
Hawse, W. F. [1 ]
Sheehan, R. P. [2 ]
Boggess, W. C. [3 ]
Faeder, J. R. [2 ]
机构：
[1] Univ Pittsburgh, Immunol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Computat & Sysems Biol, Pittsburgh, PA USA
[3] Univ Notre Dame, Notre Dame, IN 46556 USA
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1532
引用
收藏
页码：14 / 15
页数：2
相关论文
共 2 条
  • [1] Evaluation of Galectin-9 blocking mono-clonal antibodies as novel immune-checkpoint inhibitors via the targeting of regulatory T cells in cancer
    Mustapha, R.
    Mrizak, D.
    Renaud, S.
    Barjeon, C.
    de Launoit, Y.
    Pancre, V
    Morales, O.
    Busson, P.
    Delhem, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 15 - 15
  • [2] T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins
    Schlichtner, Stephanie
    Yasinska, Inna M.
    Lall, Gurprit S.
    Berger, Steffen M.
    Ruggiero, Sabrina
    Cholewa, Dietmar
    Aliu, Nijas
    Gibbs, Bernhard F.
    Fasler-Kan, Elizaveta
    Sumbayev, Vadim V.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
1